Turn Therapeutics Inc.

Healthcare

NASDAQ:TTRX · NASDAQ Global Select

Market Cap $179.62M Beta 2.77 P/E (TTM) -45.0

$5.87 -2.79%

-$0.17 today

52W Low $2.57High $26.50

Vol 0.03M · Avg 0.04M

EPS (TTM) -$0.13Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-16.14%

Period High

$9.20

Period Low

$2.71

Latest

$5.87

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Greenwich LifeSciences, Inc.

NASDAQ:GLSI

$343.76M

Opus Genetics, Inc.

NASDAQ:IRD

$335.63M

Inhibikase Therapeutics, Inc.

NASDAQ:IKT

$229.74M

TuHURA Biosciences, Inc.

NASDAQ:HURA

$150.61M

Agenus Inc.

NASDAQ:AGEN

$123.47M

Cognition Therapeutics, Inc.

NASDAQ:CGTX

$104.73M

Seer, Inc.

NASDAQ:SEER

$94.57M

Anixa Biosciences, Inc.

NASDAQ:ANIX

$89.82M

Tevogen Bio Holdings Inc.

TVGN

$43.63M

VistaGen Therapeutics, Inc.

VTGN

$22.67M

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.